A year defined by intentional choices—strengthening clinical excellence, embracing innovation, and building the personal and financial stability needed to care well for patients, teams, and family.
Living with intention means honoring time, embracing presence, and returning to purpose with a full heart.
A firewall against relapse — adjuvant immunotherapy steps into the spotlight for resected Merkel cell carcinoma.
Protecting vision, preserving the person — the promise of ocular-sparing oncology.
Two moments in small cell lung cancer — a missed opportunity and a new therapeutic option — remind us how timing and innovation continue to shape outcomes.
A year of locum work, a patient’s change of heart, and my own renewal remind me that truth, patience, and hope still matter — in medicine and in life.
Caregiving during immunotherapy means balancing vigilance with compassion — for your loved one, and for yourself.
Clinical trials aren’t about being a “guinea pig.” They’re about hope, progress, and the possibility of tomorrow’s treatments today.
The best EMR is the one that lets us spend less time clicking and more time caring.
Finding strength in small rituals and connections can transform cancer treatment from a medical journey into a deeply human one.